RTTNews | Jul 29, 2021 05:19PM EDT

17:19 Thursday, July 29, 2021 (RTTNews.com) - Ligand Pharmaceuticals Inc (LGND) revealed earnings for its second quarter that increased from last year.

The company's bottom line totaled $30.73 million, or $1.79 per share. This compares with $22.09 million, or $1.32 per share, in last year's second quarter.

Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $28.03 million or $1.63 per share for the period.

Analysts had expected the company to earn $1.34 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 102.0% to $83.68 million from $41.42 million last year.

Ligand Pharmaceuticals Inc earnings at a glance:

-Earnings (Q2): $28.03 Mln. vs. $16.66 Mln. last year.-EPS (Q2): $1.63 vs. $1.00 last year.-Analysts Estimate: $1.34-Revenue (Q2): $83.68 Mln vs. $41.42 Mln last year.

-Guidance:Full year EPS guidance: $5.80 - $6.05Full year revenue guidance: $265 - $275 Mln

Read the original article on RTTNews ( https://www.rttnews.com/3213815/ligand-pharmaceuticals-inc-q2-adjusted-earnings-beat-estimates.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved